カテゴリ： IMARC, 世界, 医療/バイオ

世界の創傷治療用生物製剤市場予測2023年-2028年

■ 英語タイトル：Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23JLY290）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23JLY290
■ 発行日：2023年7月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：146
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の創傷治療用生物製剤市場予測2023年-2028年]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社は、2022年19億ドルであった世界の創傷治療用生物製剤市場規模が、予測期間中（2023年～2028年）年平均8.5％成長し、2028年には32億ドルに達すると予測しています。当調査資料では、創傷治療用生物製剤の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（生物学的皮膚代替物、外用剤）分析、創傷種類別（潰瘍、外科的＆外傷性創傷、熱傷）分析、用途別（急性創傷、慢性創傷、外科創傷）分析、エンドユーザー別（病院、ASC、火傷センター＆創傷クリニック）分析、地域別（アジア太平洋、ヨーロッパ、北米、中東/アフリカ、中南米）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。なお、当市場の主要企業には、Smith & Nephew、Mölnlycke Health Care、Integra lifesciences、Osiris Therapeutics、Avita Medical、ConvaTec Group、Cytori Therapeutics、Mylan、Johnson & Johnson、Leap Therapeutics、Nuo Therapeutics、Mallinckrodt、Wright Medical、Mimedx Group and Solsys Medicalなどが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の創傷治療用生物製剤市場規模：製品別
- 生物学的皮膚代替物の市場規模
- 外用剤の市場規模
・世界の創傷治療用生物製剤市場規模：創傷種類別
- 潰瘍における市場規模
- 外科的＆外傷性創傷における市場規模
- 熱傷における市場規模
・世界の創傷治療用生物製剤市場規模：用途別
- 急性創傷における市場規模
- 慢性創傷における市場規模
- 外科創傷における市場規模
・世界の創傷治療用生物製剤市場規模：エンドユーザー別
- 病院における市場規模
- ASCにおける市場規模
- 火傷センター＆創傷クリニックにおける市場規模
・世界の創傷治療用生物製剤市場規模：地域別
- アジア太平洋の創傷治療用生物製剤市場規模
- ヨーロッパの創傷治療用生物製剤市場規模
- 北米の創傷治療用生物製剤市場規模
- 中東/アフリカの創傷治療用生物製剤市場規模
- 中南米の創傷治療用生物製剤市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

Market Overview 2023-2028:

The global wound care biologics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global wound care biologics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, wound type, application and end-user.

Breakup by Product:
Biologic Skin Substitutes
Human Donor Tissue-Derived Products
Acellular Animal-Derived Products
Biosynthetic Products
Topical Agents

Breakup by Wound Type:
Ulcers
Diabetic Foot Ulcers
Venous Ulcers
Pressure Ulcers
Others
Surgical and Traumatic Wounds
Burns

Breakup by Application:
Acute Wound
Chronic Wound
Surgical Wound

Breakup by End-User:
Hospitals
ASCs
Burn Centres and Wound Clinics

Breakup by Region:
Asia Pacific
Europe
North America
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Mölnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group and Solsys Medical, etc.

Key Questions Answered in This Report:
How has the global wound care biologics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global wound care biologics industry?
What has been the impact of COVID-19 on the global wound care biologics industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the wound type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global wound care biologics industry?
What are the key driving factors and challenges in the global wound care biologics industry?
What is the structure of the global wound care biologics industry and who are the key players?
What is the degree of competition in the global wound care biologics industry?

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Wound Care Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by Wound Type
5.6 Market Breakup by Application
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Product
6.1 Biologic Skin Substitutes
6.1.1 Market Trends
6.1.2 Market Breakup by Type
6.1.2.1 Human Donor Tissue-Derived Products
6.1.2.2 Acellular Animal-Derived Products
6.1.2.3 Biosynthetic Products
6.1.3 Market Forecast
6.2 Topical Agents
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Wound Type
7.1 Ulcers
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Diabetic Foot Ulcers
7.1.2.2 Venous Ulcers
7.1.2.3 Pressure Ulcers
7.1.2.4 Others
7.1.3 Market Forecast
7.2 Surgical and Traumatic Wounds
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Burns
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Acute Wound
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Chronic Wound
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Surgical Wound
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End-User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 ASCs
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Burn Centres and Wound Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 Asia Pacific
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 North America
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Smith & Nephew
15.3.2 Mölnlycke Health Care
15.3.3 Integra lifesciences
15.3.4 Osiris Therapeutics
15.3.5 Avita Medical
15.3.6 ConvaTec Group
15.3.7 Cytori Therapeutics
15.3.8 Mylan
15.3.9 Johnson & Johnson
15.3.10 Leap Therapeutics
15.3.11 Nuo Therapeutics
15.3.12 Mallinckrodt
15.3.13 Wright Medical
15.3.14 Mimedx Group
15.3.15 Solsys Medical

Figure 1: Global: Wound Care Biologics Market: Major Drivers and Challenges
Figure 2: Global: Wound Care Biologics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Wound Care Biologics Market: Breakup by Product (in %), 2022
Figure 4: Global: Wound Care Biologics Market: Breakup by Wound Type (in %), 2022
Figure 5: Global: Wound Care Biologics Market: Breakup by Application (in %), 2022
Figure 6: Global: Wound Care Biologics Market: Breakup by End-User (in %), 2022
Figure 7: Global: Wound Care Biologics Market: Breakup by Region (in %), 2022
Figure 8: Global: Wound Care Biologics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Wound Care Biologics Industry: SWOT Analysis
Figure 10: Global: Wound Care Biologics Industry: Value Chain Analysis
Figure 11: Global: Wound Care Biologics Industry: Porter’s Five Forces Analysis
Figure 12: Global: Wound Care Biologics (Biologic Skin Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Wound Care Biologics (Biologic Skin Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Wound Care Biologics (Topical Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Wound Care Biologics (Topical Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Wound Care Biologics (Ulcers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Wound Care Biologics (Ulcers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Wound Care Biologics (Burns) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Wound Care Biologics (Burns) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Wound Care Biologics (Acute Wound) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Wound Care Biologics (Acute Wound) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Wound Care Biologics (Chronic Wound) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Wound Care Biologics (Chronic Wound) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Wound Care Biologics (Surgical Wound) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Wound Care Biologics (Surgical Wound) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Wound Care Biologics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Wound Care Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Wound Care Biologics (ASCs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Wound Care Biologics (ASCs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia Pacific: Wound Care Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia Pacific: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: North America: Wound Care Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: North America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Europe: Wound Care Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Europe: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Middle East and Africa: Wound Care Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Middle East and Africa: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Latin America: Wound Care Biologics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Latin America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2023-2028

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の陰圧閉鎖療法（NPWT）市場予測2023年-2028年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23JLY290 )"世界の創傷治療用生物製剤市場予測2023年-2028年" (英文：Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。